Related Experiment Video
Updated: Apr 15, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.9K
Lipid levels and renal function decline in pre-dialysis patients
Moniek C M de Goeij1, Joris I Rotmans2, Xanthe Matthijssen1
1Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Nephron Extra
|April 9, 2015
Summary
High LDL cholesterol accelerates kidney function decline in pre-dialysis patients. This study highlights the importance of managing lipid levels for kidney health, even with medication.
Area of Science:
- Nephrology
- Cardiology
- Metabolic Disorders
Background:
- Limited understanding of lipid profiles' impact on renal function in pre-dialysis care.
- Focus on low-density lipoprotein (LDL) cholesterol, triglycerides (TG), and high-density lipoprotein (HDL) cholesterol.
Purpose of the Study:
- To investigate the association between lipid levels and renal function decline in patients undergoing pre-dialysis care.
- To compare renal function decline based on adherence to target lipid goals.
Main Methods:
- Prospective PREPARE-2 study involving incident pre-dialysis patients (n=306).
- Data collected every 6 months; linear mixed models used for analysis.
- Comparison of renal function decline between patients above and below target LDL cholesterol, TG, and HDL cholesterol levels.
Main Results:
- Patients with LDL cholesterol above target (<2.50 mmol/l) showed accelerated renal function decline.
- A trend towards accelerated decline was observed for high TG levels and low HDL/LDL ratio.
- Findings remained consistent after adjusting for confounders and excluding patients on lipid-lowering medication.
Conclusions:
- Elevated LDL cholesterol is independently associated with faster renal function decline in pre-dialysis patients.
- Management of LDL cholesterol is crucial for preserving kidney function in this population.
More Related Videos
Related Concept Videos
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
329
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
329
01:17Factors Affecting Renal Clearance: Renal Impairment
560
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
560
01:24Chronic Kidney Disease II: Clinical Manifestations
1.0K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.0K
01:11Renal Failure: Dose Adjustments
624
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
624
01:28Chronic Kidney Disease III: Interprofessional Care
647
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
647
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
332
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
332